Grant: Master's Award: Canada Graduate Scholarships
McGill University
$27,000.00
Ribonucleic Acid-Based Diagnosis of Arthrogryposis Multiplex Congenita Using Urine-Derived Cells
FY 2024-25
Summary
Arthrogryposis multiplex congenita (AMC) is the congenital presence of contractures across multiple parts of the body. Underlying conditions can be genetic, but affected individuals may not yet have received a genetic diagnosis, even after whole-genome sequencing of genomic deoxyribonucleic acid (DNA). Our laboratory has previously used ribonucleic acid (RNA)-based diagnostic methods with urine-derived cells to non-invasively study splice variants in patients with bone disorders. We intend to use these methods to identify genetic variants underlying AMC in patients with uninformative genetic testing results, potentially providing these individuals with diagnoses that could inform their care.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
560291
Name
Kerr Lauren
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Ribonucleic Acid-Based Diagnosis of Arthrogryposis Multiplex Congenita Using Urine-Derived Cells
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arthrogryposis Multiplex Congenita; Cell Culture; Diagnosis; Genetics; Rare Disorders; Rna Sequencing; Urine-Derived Cells
Abstract
Arthrogryposis multiplex congenita (AMC) is the congenital presence of contractures across multiple parts of the body. Underlying conditions can be genetic, but affected individuals may not yet have received a genetic diagnosis, even after whole-genome sequencing of genomic deoxyribonucleic acid (DNA). Our laboratory has previously used ribonucleic acid (RNA)-based diagnostic methods with urine-derived cells to non-invasively study splice variants in patients with bone disorders. We intend to use these methods to identify genetic variants underlying AMC in patients with uninformative genetic testing results, potentially providing these individuals with diagnoses that could inform their care.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kerr, Lauren
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~